XML 59 R35.htm IDEA: XBRL DOCUMENT v2.4.0.6
Segment Data (Tables)
12 Months Ended
Mar. 31, 2013
Segment Data  
Schedule of business segment information

The following tables set forth our segment information (in thousands):

 

 

 

Year ended March 31, 2013

 

 

 

Biological
Indicators

 

Instruments

 

Total

 

Revenues

 

$

21,464

 

$

24,971

 

$

46,435

 

 

 

 

 

 

 

 

 

Gross profit

 

$

12,365

 

$

16,497

 

$

28,862

 

Selling expenses

 

1,552

 

3,078

 

4,630

 

 

 

$

10,813

 

$

13,419

 

24,232

 

Reconciling items(1)

 

 

 

 

 

(11,254

)

Earnings before income taxes

 

 

 

 

 

$

12,978

 

 

 

 

Year ended March 31, 2012

 

 

 

Biological
Indicators

 

Instruments

 

Total

 

Revenues

 

$

20,422

 

$

19,194

 

$

39,616

 

 

 

 

 

 

 

 

 

Gross profit

 

$

11,236

 

$

12,275

 

$

23,511

 

Selling expenses

 

1,607

 

2,302

 

3,909

 

Impairment of intangible asset

 

 

350

 

350

 

 

 

$

9,629

 

$

9,623

 

19,252

 

Reconciling items(1)

 

 

 

 

 

(6,921

)

Earnings before income taxes

 

 

 

 

 

$

12,331

 

 

 

 

Year ended March 31, 2011

 

 

 

Biological
Indicators

 

Instruments

 

Total

 

Revenues

 

$

16,822

 

$

17,405

 

$

34,227

 

 

 

 

 

 

 

 

 

Gross profit

 

$

8,918

 

$

10,650

 

$

19,568

 

Selling expenses

 

1,554

 

2,133

 

3,687

 

 

 

$

7,364

 

$

8,517

 

15,881

 

Reconciling items(1)

 

 

 

 

 

(6,130

)

Earnings before income taxes

 

 

 

 

 

$

9,751

 

 

(1) Reconciling items include general and administrative, research and development, and other expenses.

Schedule of revenues from external customers based upon locations to which product is shipped or exported

Revenues from external customers are attributed to individual countries based upon locations to which the product is shipped or exported, as follows (in thousands):

 

 

 

Year ended March 31,

 

 

 

2013

 

2012

 

2011

 

Revenues from unaffiliated customers

 

 

 

 

 

 

 

United States

 

$

28,590

 

$

23,770

 

$

21,053

 

Foreign

 

17,845

 

15,846

 

13,174

 

 

 

$

46,435

 

$

39,616

 

$

34,227

 

Schedule of reconciliation of total assets by reportable segment to total consolidated assets

 

 

 

March 31,

 

 

 

2013

 

2012

 

Total assets

 

 

 

 

 

Biological Indicators

 

$

27,558

 

$

28,887

 

Instruments

 

31,782

 

13,572

 

Corporate and administrative

 

6,579

 

8,237

 

 

 

$

65,919

 

$

50,696